Security key
45783C101
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)
CUSIP: 45783C101
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, $0.000001 par value per share
- Total 13F shares
- 119,227,879
- Total 13F value
- $550,824,336
- Share change
- +1,370,670
- SEC-reported price per share
- $4.62
- Number of holders
- 91
- Value change
- -$14,427,751
- Number of buys
- 57
- Number of sells
- 23
- Shares outstanding
- 6,795,789
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
91
Top holders
10
TIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45783C101
Recent filing periods:
Ownership snapshot
Top reported holders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Curative Ventures V LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 559%
Showing 1-6 of 15 holder rows.
Quick read
Curative Ventures V LLC leads the comparable SEC ownership view at 559%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Curative Ventures V LLC's linked filing trail.
Comparable ownership
Top 5
Curative Ventures V LLC
559%
FMR LLC
267%
Vivo Capital, LLC
184%
CPMG Inc
121%
Venrock Adviser, LLC
101%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Curative Ventures V LLC |
13F
Company
|
559%
|
$408,285
37,980,073 shares
|
— | 31 Mar 2022 |
| FMR LLC |
13F
Company
|
267%
|
$194,981,000
18,137,713 shares
|
— | 31 Mar 2022 |
| Vivo Capital, LLC |
13F
Company
|
184%
|
$134,233,000
12,486,787 shares
|
— | 31 Mar 2022 |
| CPMG Inc |
13F
Company
|
121%
|
$88,349,000
8,218,467 shares
|
— | 31 Mar 2022 |
| Venrock Adviser, LLC |
13F
Company
|
101%
|
$73,800,000
6,865,076 shares
|
— | 31 Mar 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
72%
|
$52,361,000
4,870,793 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
91
Shares
119,227,879
Rows available
91
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
74
Q2 2022 holders
91
Holder diff
17
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend